Casma Therapeutics

Casma Therapeutics

Casma Therapeutics

We're harnessing the natural process of autophagy to design powerful new medicines for a broad range of diseases.
Type
B2c
Founded
2017
Raised
$108.5M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$50,000,000
Venture capital (Series B) - 2020
Third Rock Ventures Eventide Asset Management LLC +2
$58,500,000
Venture capital (Series A) - 2018
Third Rock Ventures
Team Size
1–10
Employees
Pulse 2.0

Casma Therapeutics Raises $50 Million In Series B

$50,000,000 Venture capital (Series B)
FinSMEs , WSJ Venture Capital

Casma Therapeutics Raises $50M in Series B Financing

$58,500,000 Venture capital (Series A)
FinSMEs , PE HUB

Casma Therapeutics Raises $58.5M in Series A Funding

Science Health